Trials / Completed
CompletedNCT03607409
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Role of Inhibin A as Biomarker for Ovarian Response to Stimulation With Gonadotropins for IVF Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- ART Fertility Clinics LLC · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol
Detailed description
Inhibin A could be an improved biomarker regarding the number of expected mature oocytes compared to estradiol.
Conditions
Timeline
- Start date
- 2018-09-09
- Primary completion
- 2019-01-29
- Completion
- 2019-07-04
- First posted
- 2018-07-31
- Last updated
- 2019-08-08
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT03607409. Inclusion in this directory is not an endorsement.